These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 33429918)

  • 21. Metformin treatment of PCOS during adolescence and the reproductive period.
    La Marca A; Artensio AC; Stabile G; Volpe A
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):3-7. PubMed ID: 15941616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of metformin in the treatment of polycystic ovary syndrome.
    Genazzani AD; Ricchieri F; Lanzoni C
    Womens Health (Lond); 2010 Jul; 6(4):577-93. PubMed ID: 20597621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
    Gateva A; Unfer V; Kamenov Z
    Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.
    Nardo LG; Rai R
    Gynecol Endocrinol; 2001 Oct; 15(5):373-80. PubMed ID: 11727360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women.
    He Y; Lu Y; Zhu Q; Wang Y; Lindheim SR; Qi J; Li X; Ding Y; Shi Y; Wei D; Chen ZJ; Sun Y
    Am J Obstet Gynecol; 2019 Aug; 221(2):138.e1-138.e12. PubMed ID: 30910544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003053. PubMed ID: 19588338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin and the control of female reproductive functions.
    Palin MF; Bordignon VV; Murphy BD
    Vitam Horm; 2012; 90():239-87. PubMed ID: 23017719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of polycystic ovaries in women with a history of gestational diabetes.
    Kousta E; Cela E; Lawrence N; Penny A; Millauer B; White D; Wilson H; Robinson S; Johnston D; McCarthy M; Franks S
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):501-7. PubMed ID: 11012576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
    Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
    Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options.
    De Leo V; Musacchio MC; Palermo V; Di Sabatino A; Morgante G; Petraglia F
    Drugs Today (Barc); 2009 Oct; 45(10):763-75. PubMed ID: 20069140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.
    Costello MF; Eden JA
    Fertil Steril; 2003 Jan; 79(1):1-13. PubMed ID: 12524053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome and metformin in pregnancy.
    Lilja AE; Mathiesen ER
    Acta Obstet Gynecol Scand; 2006; 85(7):861-8. PubMed ID: 16817087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.